Skip to main content
VCbacked
Log inGet Started

Lymphatica Medtech

Ecublens, Switzerland

Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.

$19.6M raised
Oct 2024
Series B
BiotechnologyHealth CareMedicalMedical Device

Top Investors

HTGF (High-Tech Gruenderfonds)CDP Venture CapitalPanakes PartnersZúrcher Kantonal BankMassChallenge

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lymphatica Medtech

How much funding has Lymphatica Medtech raised?
Lymphatica Medtech has raised $19.6M in total funding. The most recent round was Series B. The last funding was announced in October 2024.
Who are Lymphatica Medtech's investors?
Lymphatica Medtech's investors include HTGF (High-Tech Gruenderfonds), CDP Venture Capital, Panakes Partners, Zúrcher Kantonal Bank, MassChallenge.
Where is Lymphatica Medtech headquartered?
Lymphatica Medtech is headquartered in Ecublens, Switzerland.
What does Lymphatica Medtech do?
Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.
What stage is Lymphatica Medtech at?
Lymphatica Medtech is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Lymphatica Medtech — Funding & Investors." VCBacked, October 8, 2024, https://www.vcbacked.co/company/lymphatica-medtech. Accessed June 4, 2026.
APA
VCBacked. (2024). Lymphatica Medtech — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/lymphatica-medtech
Wikipedia (cite web)
{{cite web |title=Lymphatica Medtech — Funding & Investors |url=https://www.vcbacked.co/company/lymphatica-medtech |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong